Worldwide Healthcare News

  The world smart pills technology market would reach $627.1 million by 2020, registering a CAGR of 21.2% during 2015-2020. Smart pill is a technological  innovation that has bridged the unsought gap between healthcare and digital technology. The advent of novel smart pill technologies has revolutionized gastrointestinal (GI) monitoring and diagnosis techniques. Non-invasiveness, patient convenience and real time monitoring offered by smart pills boost their adoption in the treatment of numerous diseases. The growth of global smart pills technology market is supplemented by the growing adoption of capsule endoscopy, spurring demand for smart pills in GI monitoring and the rising prevalence of gastrointestinal diseases. However, factors such as high costs, limited technical know-how and low acceptance among patients (fear of ingesting electronic devices) are likely to restrain the growth of the market. Key finding of the study   Capsule endoscopy accounted for th...

  Body contouring devices have gained a substantial market share in recent years due to rise in obesity globally. In addition, surge in esthetic consciousness across the globe is another major factor that in turn has fueled the use of body contouring devices. Furthermore, untapped potential in the emerging markets in Asia-Pacific is anticipated to boost the market growth in the future.  The global  body contouring devices market  was valued at $933 million in 2017 and is projected to reach $3,446 million in 2025, registering a CAGR of 17.7% from 2018 to 2025. The report segments the global body contouring devices market into product, application, end user, and region. Based on product, non-invasive devices contributed to nearly three-fifths of the total market share in 2017 and would grow at the highest CAGR of 18.1% from 2018 to 2025. This is due to its ability to offer lesser risk and pain as compared to traditional surgical devices and procedures. Based on applica...

  Significant surge in the number of hospitals and clinics across the globe is the major factor that drives the market growth. In addition, rise in number of surgical procedures contributes to the market growth . The global  surgical lights market  size is expected to reach $3,838 million by 2026, registering a CAGR of 4.5% from 2019 to 2026, in terms of value.  Significant rise in surgical procedures, and surge in technological developments in surgical lights drive the growth of the global surgical lights market. On the other hand,high cost of LED lights restrains the growth to some extent. However, various growth opportunities in emerging economies are expected to create a number of opportunities in the industry. Request Sample Report at:   https://www.alliedmarketresearch.com/request-sample/6441    The halogen segment to lead the trail till 2026- Based on type, the halogen segment accounted for more than half of the global surgical lights market sha...

  Increase in demand for injectable drug delivery devices across the globe and rise in incidence of chronic diseases act as the major driving forces for the global syringes market. Furthermore, increase in demand for technologically advanced syringes notably contribute toward the growth of the market. The global  syringes market  size was valued at $15,340 million in 2019, and is projected to reach $32,394.74 million by 2027, growing at a CAGR of 9.6% from 2020 to 2027. Upsurge in incidence of needle stick injuries, rise in awareness about smart syringes, and high-end technological advancements fuel the growth of the global syringes market. On the other hand, high cost and unaffordability of safety syringes and alternative modes of drug delivery impede the growth to some extent. However, increase in need for safety syringes in emerging economies is expected to create lucrative opportunities in the industry. Covid-19 scenario- The outbreak of the pandemic led to huge disru...

  Demand for clinical trial imaging services is on the rise, owing to surge in adoption of imaging in clinical trials, rise in chronic disorders across the globe which leads to surge in clinical trials that require imaging leading to outsourcing of these services. Furthermore, surge in cost associated with conducting clinical trials in house also leads to surge in demand for imaging services offered by CROs thereby boosting the market growth. The global  clinical trial imaging services market  was valued at $1.3 billion in 2019, and is expected to reach $1.8 billion by 2027, registering a CAGR of 5.6% from 2019 to 2027.  Rise in the need to outsource imaging in clinical trials, growth in adoption of imaging in clinical trials, and developments in the field of medical imaging technology drive the global clinical trial imaging services market. However, challenges associated with integration of imaging in clinical trials restrain the market growth. On the other hand, pr...

  Increase in demand for LFIA based rapid test kits across geographies along with rise in target population is majorly driving the market growth. Furthermore, surge in prevalence of infectious disease along with rise in demand for rapid test is expected to boost the requirement of LFIA based rapid test in the coming years.  The global  LFIA based rapid test market  size was valued at $4.72 billion in 2018, and is expected to reach $8.50 billion by 2026, growing at a CAGR of 7.6% from 2019 to 2026.  The infectious disease segment to retain its dominance till 2026- Based on application, the infectious disease segment contributed to more than four-fifths of the global  l ateral flow immunoassay based rapid test market share in 2018, and is expected to rule the roost throughout the study period. Increase in initiatives by the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services, Food and Drug Administration, and National Ins...

  Surge in usage of wireless monitoring devices and increase in population of aging people across the globe drive the growth of the global patient monitoring devices market. However, high cost associated with patient monitoring devices is anticipated to restrain the market growth. Furthermore, increasing technological advancements are expected to provide new opportunities during the forecast period. The  Patient Monitoring Devices Market  generated $25.76 billion in 2019, and is estimated to reach $44.86 billion by 2027, registering a CAGR of 4.4% from 2020 to 2027. Based on product type, the cardiac monitoring devices segment contributed to the largest share in 2019, accounting for more than one-fourth of the total share, and is estimated to maintain its dominant position during the forecast period. However, the remote patient monitoring devices segment is estimated to portray the highest CAGR of 6.3% during the forecast period. Based on end-user, the hospitals segment a...